CJC-1295 vs Sermorelin
Both are categorized under GH release in our directory—here is how they differ in name, use, and label context.
Both are categorized under GH release in our directory—here is how they differ in name, use, and label context.
PubMed paper counts, ClinicalTrials.gov listings, and regulatory context—aggregated from public databases.
GH release
A long-acting GHRH analog that extends GH pulses—often stacked with ipamorelin.
CJC-1295 mimics growth hormone-releasing hormone. The DAC version binds albumin for a longer half-life. Intended effects: lean mass support, sleep quality, and recovery. Prescription analogs exist in different forms; gra…
GH release
A GHRH analog that prompts the pituitary to release growth hormone—often stacked with GHRP peptides in clinic and research conversations.
Sermorelin mimics the first 29 amino acids of growth-hormone-releasing hormone. It stimulates pulsatile GH release rather than supplying GH directly. It was FDA-approved as a diagnostic (Geref) but is widely discussed of…
Both are categorized under GH release in our directory—here is how they differ in name, use, and label context. CJC-1295 is categorized as GH release; Sermorelin as GH release. CJC-1295: A long-acting GHRH analog that extends GH pulses—often stacked with ipamorelin. Sermorelin: A GHRH analog that prompts the pituitary to release growth hormone—often stacked with GHRP peptides in clinic and research conversations.
No. They are different molecules with distinct names on labels and in research databases. Always match the full INCI or drug name—not a nickname on the front of the package.
Neither page is medical or anti-doping advice. Research peptides discussed in fitness communities may be prohibited in tested sport or unavailable as OTC supplements. Verify WADA lists and talk to a clinician.